The influence of liver metastases on the pharmacokinetics of doxorubicin---a population-based pharmacokinetic project of the CESAR-APOH.

International journal of clinical pharmacology and therapeutics

Volumn 41, Issue 12, 2003, Pages 598-599

  Muller H J ^a   Port, R E ^a   Grubert, M ^a   Hilger, R A ^a   Scheulen, M ^a   Mross, K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ASPARTATE AMINOTRANSFERASE; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 1542752279     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41598     Document Type: Article

References (0)